Pathology of Hepatitis c Nephropathy (NCT03476031) | Clinical Trial Compass
UnknownNot Applicable
Pathology of Hepatitis c Nephropathy
Egypt50 participantsStarted 2018-11
Plain-language summary
Hepatitis c associated glomerulonephritis is an immune complex disease that occurs in 21% of patients who have HCV infection.
Who can participate
Age range20 Years – 60 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* it will be conducted on chronic hepatitis C patients with chronic kidney disease .
* The participants will be classified according to their estimated GFR by modified MDRD equation and
* they will be recruited from the renal unit of internal medicine, Assiut University Hospitals and assiut hepatitis viruses unit-ministry of health, Egypt.
Exclusion Criteria:
Patients will be excluded if the underlying causes of CRF are as follows:
chronic pyelonephritis,obstructive uropathy,Polycystic kidney disease,Patients with ESRD on regular hemodialysis,patients with advanced liver cirrhosis,hepatocellular carcinoma,Patients on steroids or immunosuppressive drugs and Solitary kidney.
What they're measuring
1
prevalence of histopathological pattern in patients with hepatitis C virus